Executive Summary
The PTAB held that Apple’s wearable physiological measurement claims were obvious over prior‑art pulse‑oximetry references, rendering all challenged claims unpatentable. The decision relied on Lisogurski, Carlson, and Mannheimer teachings.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in SAMSUNG ELECTRONICS CO., LTD. et al. vs OMNI MEDSCI, INC. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
FormFactor, Inc.vsTechnoprobe S.p.A.
FormFactor and Technoprobe have settled their IPR dispute over a probe‑card patent. They jointly request that the settlement agreement be treated as confidential business information, effectively terminating the proceeding.
Eunsung Global Corp.vsHydraFacial LLC et al.
Eunsung Global and HydraFacial jointly filed a motion asking the PTAB to keep their settlement agreement confidential and separate from the patent file, invoking 35 U.S.C. §317 and related regulations.
Garmin International, Inc.vsCardiacsense LTD
Garmin International successfully navigated the initial stages of its IPR challenge against Cardiacsense LTD's '998 patent, establishing a reasonable likelihood of prevailing on several grounds. The Board found that certain claims were not entitled to an earlier effective filing date due to insufficient written description support for a compass feature in prior applications.
Amphenol CorporationvsCredo Technology Group Ltd.
The ITC investigation into switchable‑connectivity phones and tablets was terminated after Ericsson and Apple filed a joint motion to end the case based on a settlement. The Commission found no reason to deny the motion and declined to review the initial determination.
EP Family Corp.vsOffice Kick Inc.
EP Family Corp. and Office Kick, Inc. settled their dispute and jointly moved to terminate the IPR before any institution, resulting in a confidential settlement and dismissal of the proceedings.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.